Literature DB >> 35021075

Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function.

Md Masud Alam1, Xiao-Qing Li1, Jia Liu1, Timothy Carrel Back1, Anna Trivett1, Baktiar Karim2, Denise Barbut3, Michael Zasloff4, Joost J Oppenheim5.   

Abstract

Alpha-synuclein (αS) is causally involved in the development of Parkinson disease (PD); however, its role in normal vertebrate physiology has remained unknown. Recent studies demonstrate that αS is induced by noroviral infection in the enteric nervous system of children and protects mice against lethal neurotropic viral infection. Additionally, αS is a potent chemotactic activator of phagocytes. In this report, using both wild-type and αS knockout mice, we show that αS is a critical mediator of inflammatory and immune responses. αS is required for the development of a normal inflammatory response to bacterial peptidoglycan introduced into the peritoneal cavity as well as antigen-specific and T cell responses following intraperitoneal immunization. Furthermore, we show that neural cells are the sources of αS required for immune competence. Our report supports the hypothesis that αS accumulates within the nervous system of PD individuals because of an inflammatory/immune response. Published by Elsevier Inc.

Entities:  

Keywords:  Parkinson disease; alarmins; alpha-synuclein; dendritic cells; immune response; immunization; inflammation; macrophage; peritoneal cavity; αS

Mesh:

Substances:

Year:  2022        PMID: 35021075     DOI: 10.1016/j.celrep.2021.110090

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

Review 1.  New Perspectives on Immune Involvement in Parkinson's Disease Pathogenesis.

Authors:  David Gate
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies.

Authors:  Miriam Højholt Terkelsen; Ida H Klaestrup; Victor Hvingelby; Johanne Lauritsen; Nicola Pavese; Marina Romero-Ramos
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

3.  Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease.

Authors:  Jonas Folke; Emil Bergholt; Bente Pakkenberg; Susana Aznar; Tomasz Brudek
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

Review 4.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

Review 5.  Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner.

Authors:  Wenbin Liu; Meiyang Fan; Wen Lu; Wenhua Zhu; Liesu Meng; Shemin Lu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 6.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 7.  Supramolecular organizing centers at the interface of inflammation and neurodegeneration.

Authors:  Petra Sušjan-Leite; Taja Železnik Ramuta; Elvira Boršić; Sara Orehek; Iva Hafner-Bratkovič
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 8.  Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis.

Authors:  Szu-Ju Chen; Chin-Hsien Lin
Journal:  J Biomed Sci       Date:  2022-07-27       Impact factor: 12.771

Review 9.  Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age.

Authors:  Ashley Payne; Samuel Nahashon; Equar Taka; Getinet M Adinew; Karam F A Soliman
Journal:  Biomolecules       Date:  2022-02-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.